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ABSTRACT: 
 
ROLE OF INOSITOL 1,4,5-TRIPHOSPHATE ON HEART RATE 
IN ISOLATED HEART MODELS OF WISTAR RATS 
 
                  The sodium calcium exchanger (NCX) is emerging as the primary 
pacemaking mechanism in heart. It extrudes 1 Calcium ion for 3 Sodium ions 
taken into the cell (forward mode of NCX), thereby producing an inward 
current which depolarizes the cell. Calcium should be available in cytoplasm 
to drive NCX in forward mode. Diastolic calcium release from sarcoplasmic 
reticulum (SR) provides for calcium to drive forward NCX. But the route(s) 
of calcium release from SR is/are to be confirmed. 
          In this study we wanted to see the role of Inositol1,4,5-triphosphate 
receptor (IP3R) in diastolic calcium release. If it is involved, stimulating 
IP3R should increase heart rate and decreasing IP3 formation should 
decrease heart rate.  In this study rat hearts were isolated and perfused with 
normal extracellular solution in Langendorff mode and the heart rate was 
recorded. Phenylephrine, an IP3 agonist was added to the perfusate and its 
effect on heart rate was recorded (n=6).  Neomycin which blocks the 
production of IP3 was added along with Phenylephrine in another set of 
experiments and the effects on heart rate was recorded (n=6). The change in 
heart rate was compared and analysed using Wilcoxon Signed Rank test.  
 
 
         
 
                Our results showed a 44% increase in heart rate with 
Phenylephrine   (p = 0.028). With Neomycin the Phenylephrine-induced 
increase in heart rate was blocked. This confirms that the positive 
chronotropic effect of Phenylephrine is through IP3. The study confirms that 
IP3 has a positive chronotropic effect. This opens a whole new portal of 
pharmaco-therapeutics in the management of cardiovascular pathologies like 
arrhythmias. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION: 
 
  The research on the molecular mechanism behind the cardiac 
pacemaker activity has lead to the identification of ion channels involved in 
generating cardiac action potential and their encoding genes. Sinoartial node is 
the primary pacemaker of the heart. The Sinoatrial node action potential is 
different from the action potential of other working cardiomyocytes. The 
Sinoatrial node action potential has a diastolic depolarisation during phase 4 
which is responsible for the spontaneous production of action potential. The 
ionic mechanism behind this diastolic depolarisation is responsible for the 
pacemaker activity of heart and this has studied extensively.  
                    In 1979, the funny currents (If) was discovered by Noble et al and 
these currents were called as the pacemaker currents. These funny currents 
through HCN (hyperpolarisation activated cyclic nucleotide gated) channels 
get activated on hyperpolarisation. So at the end of repolarisation phase when 
the membrane potential is more negative, these channels get activated 
producing an inward current and thereby diastolic depolarisation (Brown et al., 
1979). Since this HCN channel which is present in the membrane is 
responsible for the diastolic depolarisation, this theory is called the membrane 
clock theory. 
                    Later studies using confocal imaging and immunoflorescence 
showed that an intracellular calcium clock activates the membrane ion 
 
 
channels and produce action potential. This intracellular calcium clock is 
described as a spontaneous, regular and rhythmic local calcium release (LCR) 
from sarcoplasmic reticulum which occurs before the next action potential. 
This local calcium release activates sodium calcium exchanger in forward 
mode producing an inward current and depolarisation (Bogdanov et al., 2001). 
Since the intracellular calcium release initiates action potential this theory is 
called „Calcium Clock‟ theory. 
                    Recent studies have shown that in cardiac pacemaker cells the 
calcium clock and the membrane clock work together to produce diastolic 
depolarisation. This is called as „coupled clock‟ theory (Yaniv and Lakatta, 
2013). 
                   The local calcium release which activates sodium calcium 
exchanger in forward mode is from sarcoplasmic reticulum. The sarcoplasmic 
reticulum has two calcium release channels namely: Ryanodine receptors and 
IP3 receptors (Inositol1,4,5-triphosphate receptors). The sarcoplasmic 
reticulum releases calcium both during systole and diastole. The sarcoplasmic 
reticular calcium release during systole is responsible for contraction and the 
sarcoplasmic reticular calcium release during diastole is responsible for 
pacemaking activity of the heart. Which of the calcium channels of the 
sarcoplasmic reticulum is responsible for diastolic calcium release is not yet 
clear. 
 
 
                  The Ryanodine receptor is activated by calcium to produce a 
calcium induced calcium release during systole (Griffiths and MacLeod, 
2003). IP3 receptors are activated by calcium and IP3 (Bootman et al., 2009). 
Hence when IP3 is bound to its receptor, even a very little amount of calcium 
as seen during diastole can activate the receptor to release more calcium 
(Gilbert et al., 1991). Hence IP3 may have a more significant role than 
Ryanodine receptor in diastolic calcium release.  
                  This study aims at assessing the role of IP3 receptor in diastolic 
depolarisation and thereby heart rate. We have used an isolated rat heart model 
perfused in Langendorff mode with normal extracellular solution at 37 degree 
Celsius and constantly oxygenated. The heart is calculated from the surface 
ECG recorded using surface electrodes. The concentration of IP3 is altered in 
the cardiac tissue using Phenylephrine (IP3 agonist) and Neomycin (IP3 
antagonist) and the change in heart rate is assessed. 
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LITERATURE 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE: 
HEART: 
                Heart is a vital organ in our body. It does the work of pumping 
blood throughout the body. Thus it carries over the functions of transport of 
gases, waste products and hormones, regulation of homeostasis and also helps 
in immunity. People have been very curious to know about heart and its 
functions right from ancient times. In 4
th
 century B.C., the Greek scientist and 
philosopher Aristotle described heart as the most important organ of the body 
and first to be formed based on his observation of chick embryos. After 
Aristotle many other great scientists like Galen and Leonardo da Vinci have 
studied heart and described about it. Later in 1628, the English physician 
William Harvey published his article called „On the circulation of the blood‟ 
which formed the basis for all the modern research and understanding of heart 
and its function. 
                  Heart is a muscular organ made of four chambers. The cardiac 
muscle is an involuntary, striated muscle. The cardiac muscle is different and 
more complex compared to the skeletal muscle.  The fibres of the cardiac 
muscle form a structural network and acts as a syncytium. The impulses that 
activate the heart are neither produced nor conducted by the nervous system as 
in skeletal muscles. The excitatory impulses of heart are produced by a group  
 
 
 
 
of specialized cells present in the right atrium called the Sinoatrial node. The 
rhythmic impulses produced by the Sinoatrial node are distributed throughout  
the heart by a special conduction system present in the heart. The conduction 
system includes the Sinoatrial node, inter-atrial fibres, Atrioventricular node, 
Bundle of His, Purkinje fibres and inter-ventricular fibres. The wall of the 
heart is made of three layers: the endocardium which forms the inner layer, the 
middle myocardium and the epicardium which forms the outer layer. 
 
 Properties of heart 
                  The heart has five electrophysiological properties. In 1897, 
Theodor Wilhelm Engelmann, a German physiologist introduced the Greek 
terms for describing the electrophysiological properties of heart. They are: 
 Chronotropy 
 Inotropy 
 Dromotropy 
 Lusitropy 
 Bathmotropy 
Chronotropy is the property of the heart to produce electrical impulse on its 
own. It is also called as automaticity. 
Inotropy is the property of the heart to contract to the electrical impulse. It is 
also called as contractility. 
 
 
 
 
Dromotropy is the property of the heart to conduct the electrical impulse. It is 
also called as conductivity. 
Lusitropy is the property of the heart to relax. 
Bathmotropy is the property of the heart to respond to stimulus. It is also 
called as excitability.  
Cardiac Action potential: 
                Rapid activation of a group of muscles which produces and 
distributes an electrical impulse is necessary for the normal sequence of 
synchronous contraction of the atrium and ventricle. This electrical impulse 
must be able to change the heart rate rapidly and to respond to any change in 
autonomic tone. All these roles are fulfilled by the cardiac action potential. A 
normal cardiac action potential has 5 phases. 
 
 
Figure 1 : Action potentials of a Sinoatrial node cell and 
ventricular muscle cell. 
 
 
 
1. Phase 4: This is also called as the resting potential. It is around -90 mV 
in working myocardial cells. It is more depolarised in the pacemaker 
cells present in the Sinoatrial node. In the pacemaker cell it is around -
50 to -65 mV and it undergoes a slow depolarization. 
2. Phase 0: This is a phase of rapid depolarization. This phase is important 
for the rapid propagation of the impulses at the velocity of 1m/s. In 
Sinoatrial node this phase is slower compared to the working 
myocardial cells. Hence there is slow propagation of impulse with 
velocity of 0.1 to 0.2 m/s (Grant, 2009).  
3. Phase 1: This is a phase of rapid repolarisation. This phase sets the 
potential for the next plateau phase. 
4. Phase 2: This phase is a plateau phase and this is the longest phase. 
This is seen only in the working myocardial cells and not in the 
Sinoatrial nodal cells. This phase marks calcium entry into the cell. 
5. Phase 3: This is a phase of rapid repolarisation. This phase restores the 
membrane potential back to the resting membrane potential (Grant, 
2009). 
 
 
 
 
 
 
 
Ion channels responsible for different phases of action potential: 
 
The action potential generation and their difference in different regions of the 
heart are due to the difference in distribution and permeability of ion channels 
in the heart. 
 
Sinoatrial nodal Action Potential: 
 
Figure 2 : Action potential in the Sinoatrial nodal cell and the ion 
channels involved in each phase 
 
The cells in Sinoatrial node donot have any true resting potential, instead they 
generate spontaneous and regular action potentials. 
 
 
                During phase 4, the Sinoatrial node action potential undergoes a 
slow depolarisation which is called as „Diastolic Depolarisation‟. At the end of 
repolarization, the membrane potential reaches a negative value of about -60 
mV. At this potential there is opening of an ion channel called HCN 
(Hyperpolarization-activated cyclic nucleotide-gated) channels which 
produces an inward current called the funny currents. This produces little 
depolarization of the membrane. At around -50 mV the T-type calcium 
channels get activated and produce more depolarization. The calcium ions 
entering the cell through this calcium channel activate calcium-induced 
calcium release from the sarcoplasmic reticulam stores through Ryanodine 
receptors and IP3 (Inositol 1,4,5-triphosphate)receptors. This increase in 
intracellular calcium drives the sodium calcium exchanger in forward mode 
and produces a depolarizing inward current. When the membrane potential 
reaches -40 mV, it activates the L- type calcium channels. Opening of this 
channel causes calcium to enter into the cell and depolarises the cell till the 
threshold potential is reached (Grant, 2009) . 
                  Phase 0 of the Sinoatrial node action potential is due to increased 
conductance of calcium ions through the open L-type calcium channels. Since 
the activation of calcium channels is not as fast as sodium channels, the rate of 
depolarization is slow compared to the working myocardial cells action 
potential. Hence this is also called as the „Slow Response‟ action potential (de 
Carvalho et al., 1969). 
 
 
                  Phase 2 is absent in the Sinoatrial nodal action potential. 
                  In Phase 3, the repolarization phase of the Sinoatrial node action 
potential occurs because of the potassium conductance through the voltage 
gated potassium channels producing an outward hyperpolarizing current.  At 
this time the calcium channels become inactivated and closed. Once the cell is 
completely repolarised and reaches -60 mV, the cycle is repeated 
spontaneously. 
 
Working cardiomyocytes/Ventricular Action potential: 
 
Figure 3 : Action potential tracing in a working myocardial cell and 
the ion channels involved in each phase 
 
 
 
 
                Atrial myocytes and ventricular myocytes are the examples of 
working myocardiocytes or non-pacemaker cells. 
               Unlike Sinoatrial nodal cells these cells have true resting membrane 
potential. This resting membrane potential remains near the equilibrium 
potential of potassium ion which is around -90 mV.  
              In Phase 4, the resting membrane potential of the working 
cardiomyocytes is around -90 mV. This is because of the potassium 
conductance as the cell is more permeable to potassium at this potential. 
                 Phase 0 occurs when these cells are depolarised by the action 
potential from the adjacent cell. There is a rapid depolarization at phase 0. 
This is due to the opening of sodium channels and increased sodium 
conductance. This is faster than the calcium conductance seen in the Sinoatrial 
nodal cells. Hence this action potential is referred to as „Fast Response‟ action  
potential (de Carvalho et al., 1969). 
                 Phase 1 is the initial repolarisation phase. This is because of 
opening of a transient outward potassium channel which produces a 
hyperpolarizing current and is short lived. 
                 Phase 2 is a plateau phase. This is because of the calcium 
conductance through the open L-type calcium channels. This plateau phase 
increases the duration of action potential. 
 
 
               Phase 3 is the repolarisation phase which occurs due to the opening 
of potassium channels and closing of calcium channels. This repolarisation 
takes the membrane to the resting membrane potential.   
 
Chronotropy 
                  Chronotropy is the property to produce electrical impulse on its 
own. Pacemaker cells are the cells with this property of Chronotropy or 
automaticity. Pacemaker cells are described as cells which can spontaneously 
depolarize from its resting membrane potential, producing an action potential 
which can then contract the cell. The electrical coupling of the neighbouring 
cells which act as a syncitium, helps in conduction of this action potential 
produced by the pacemaker cells. 
 
Self excitability seen in other cells like GIT:  
                      Pacemaker cells which have the property of Chronotropy or 
automaticity are also found in the Gastro-intestinal tract. The pacemaker cells 
present in the gut is called as Intestitial cells of Cajal. These cells generate 
slow waves which determine the frequency of the phasic contractions of 
stomach, small intestine and colon. These cells were first described by 
Santiago Ramon y Cajal  in 1911 and he called them „primitive neurons‟ 
(Cajal, 1911). These cells are spontaneously active in their resting membrane 
 
 
potentials and hence can produce action potentials. The ionic basis of the 
pacemaker mechanism in these cells is still under study. A study shows that 
the initiation of pacemaker activity is by the release of calcium from the 
internal stores through IP3 receptor which produces unitary current and 
depolarisation (Sanders et al., 2006).  
 
Pacemaker in heart 
                  Heart has pacemaker activity i.e. it can produce impulse and beat 
on its own without any neuro-humoral stimulation. This was observed as early 
as second century AD when Galen saw that even after isolating the heart from 
the body, it was beating for some time.  All the cells in the conductive system 
have the property of rhythm generation. But Sinoatrial node can produce 
impulses at highest rate (60-100 per minute) compared to other regions (AV 
node:40-55/min, purkinje system: 25-40/min) in the conductive system. Hence 
it suppresses the other areas and acts as a primary pacemaker.  
 
Diastolic depolarisation 
               The pacemaker cells have a phase called Diastolic depolarisation 
which is a depolarising phase at the end of repolarisation that brings the 
membrane to threshold potential for producing action potential. 
 
 
 
Theories of pacemaking: 
                  The ionic and molecular mechanism behind the pacemaker activity 
of the heart has been studied for a long time and many theories have been 
proposed. The discovery of hyperpolarisation activated current (If) in sinoatrial 
nodal cells and purkinje cells was a breakthrough in this research. Recently the 
importance of Sodium calcium exchanger and spontaneous intracellular 
calcium release in pacemaking has been highlighted.  
 
Membrane clock Theory: 
                   In 1979 Noble et al proposed that the diastolic depolarisation is 
due to the funny currents (If) through the HCN channels which gets activated 
on hyperpolarisation and produce an inward current (Brown et al., 1979).The 
funny current is a mixed cationic current carried by sodium and potassium. 
HCN4 gene codes for the funny currents and this is found to be expressed 
more in Sinoatrial node and it is not expressed in the surrounding atrium 
(Marionneau et al., 2005) showing that it is uniquely expressed in Sinoatrial 
node. The funny current is also called as pacemaker current. This pacemaker 
current is activated by hyperpolarisation and deactivated by depolarisation, 
working continuously like a clock. Hence this theory is called as membrane 
clock theory. 
 
 
 
 
Calcium clock Theory:  
                     Studies using confocal imaging and immunoflorescence have 
shown that intracellular calcium cycling (calcium clock) activates the 
membrane ion channels and produces action potentials. The calcium clock is 
described as a spontaneous, rhythmic, regular, intracellular local calcium 
release (LCR) from sarcoplasmic reticulum that appears before the next action 
potential. This LCR activates sodium calcium exchanger in forward mode to 
produce inward current and thereby depolarisation (Bogdanov et al., 2001). 
Thus an intracellular calcium clock that generated LCR initiates the action 
potential in pacemaker cells and this theory is called as calcium clock theory. 
 
Coupled clock theory:  
                  The coupled clock theory states that in a cardiac pacemaker cell the 
calcium clock and the membrane clock do not operate individually but work 
together through many interactions modulated by intracellular calcium, 
membrane voltage, Protein kinase A and calcium-calmodulin dependent 
protein phosphorylation (Yaniv and Lakatta, 2013).  
 
Calcium signalling 
                  Calcium is the most important second messenger which is involved 
throughout the history of a cell. It helps in producing new life by fertilisation, 
helps in development and differentiation process, involved in all control 
 
 
mechanisms like secretion, metabolism, learning and memory and it is also 
involved in cell death. Thus calcium signalling is highly versatile. 
 
Sources of calcium : 
Mechanisms of Calcium influx across plasma membrane: 
                  The normal intra-cellular concentration of calcium is about 100 
nM/L. Calcium signalling which is necessary for various processes like 
contraction, secretion, etc. occurs when there is momentary increase in the 
intracellular concentration (Calcium transient) of up to five fold. This increase 
in intracellular calcium is through influx of calcium across the plasma 
membrane or release of calcium from the intracellular stores.  
The plasma membrane calcium influx pathways are: L-type calcium channels, 
T-type calcium channels, P,Q and N-type of calcium channels, Store operated 
calcium channels (ORAI/STIM1), Sodium calcium exchanger (Reverse mode) 
and MNDA glutamate receptor (in neurons) 
 
The calcium release pathways from the intracellular stores: 
 
                   The intracellular calcium stores are mobilizable calcium pools 
found stored in organelles inside the cell like endoplasmic reticulum and 
mitochondria. The calcium is released from the endoplasmic reticulum  
 
 
through two receptors namely, the Ryanodine receptor and the IP3 receptor. 
Another calcium release pathway from mitochondria is SCaMPER 
(sphingolipid Ca2+-release-mediating protein of endoplasmic reticulum) (Mao 
et al., 1996). The calcium stored in the mitochondria is released through two 
pathways, one is a sodium dependent - mitochondrial sodium calcium 
exchanger and another is a sodium-independent calcium efflux pathway 
(Hoppe, 2010). 
 
Calcium clearing mechanisms 
                Excess calcium or persistent high levels of calcium inside the cell is 
toxic. Hence all cells have calcium limiting mechanisms and calcium clearing 
mechanisms. Example of calcium limiting mechanism is calcium dependent 
inactivation of voltage gated L-type calcium channels and calcium dependent 
inactivation of Ryanodine receptors. The calcium clearing mechanisms move 
calcium either across the plasma membrane or into the intracellular stores. 
Calcium clearing mechanism across the plasma membrane is through sodium 
calcium exchanger (NCX) in forward mode and Plasma membrane calcium 
ATPase (PMCA). Movement of calcium into the endoplasmic reticulum is 
through Sarco-endoplasmic reticular calcium ATPase (SERCA). Calcium 
uptake into mitochondria is through mitochondrial calcium uniporter (Hoppe, 
2010). 
 
 
 
Elementary calcium signals: 
                  The elementary calcium signals are visualised by confocal 
microscopy and they form the basis for calcium signalling. 
                  Local Calcium events regulate many processes like release of 
secretory vesicles, activation of ion channels and nuclear calcium signal for 
gene transcription. Since these local Calcium events are spatially limited and 
declines rapidly it has advantage compared to global Calcium events. 
Many elementary calcium release events that are non-propagatory have been 
seen in many excitable and non-excitable cells (Berridge, 1997; Bootman et 
al., 2001). The elementary calcium release event representing the calcium 
release by an individual Ryanodine receptor is called as „Calcium quarks‟ and 
by a  cluster of Ryanodine receptors is called „Calcium sparks‟. These 
Calcium sparks summate spatially and temporally to produce a global raise in 
calcium transient which is responsible for excitation contraction coupling 
(Blatter et al., 1997). 
                   IP3 receptor dependent calcium release event from a single 
receptor is termed „Calcium blips‟. Elementary calcium release event from a 
cluster of IP3 receptor is termed „Calcium puffs‟. These have been observed in 
non-excitable cells like oocytes (Parker et al., 1996) and vascular endothelial 
cells (Hüser and Blatter, 1997) . But these Calcium puffs are not seen in 
cardiac myocytes. This might be because of the lower density of IP3 receptors  
 
 
 
compared to Ryanodine receptor in these cardiac myocytes. In a study, this 
problem is solved by using a Ryanodine receptor blocker- tetracaine in 
permeabilised cat atrial myocytes. In these cells after blocking Ryanodine 
receptors, the Calcium puffs were seen and they were completely abolished by 
heparin which is an IP3 receptor blocker (Györke et al., 1997) . 
 The calcium puffs have significantly slower kinetics compared to the Calcium 
sparks. Also the calcium puffs have 75-80% smaller amplitude compared to 
calcium sparks. The calcium puffs are about 3 times long lasting and the rise 
was about twofold prolonged compared to the calcium sparks. But the spatial 
orientation and spread of both calcium sparks and calcium puffs were not 
significantly different (Berridge, 1997).  
                    All these data show that IP3 receptor mediated calcium release is 
significantly smaller compared to Ryanodine receptor mediated calcium 
release in cardiac cells. But still they can have potential role in these cells. The 
calcium puffs can summate with the calcium sparks to increase the global 
calcium transient. Also the calcium puffs themselves can activate nearby 
Ryanodine receptors to produce more calcium sparks thereby amplifying the 
sarcoplasmic calcium release. 
 
 
 
 
 
Global Ca signals - Ca waves: 
                   Increase in intracellular calcium can be spontaneous or can be 
stimulated by any neuro-humoral mechanism. This increase in intracellular 
calcium can occur at single foci or multiple foci and can lead to an elevation 
of intracellular calcium propagating throughout the cytoplasm in a wave-like 
pattern. This is called as calcium waves. These calcium waves are seen in both 
excitable and non-excitable cells (Lipp and Niggli, 1996) and they play a role 
in many signal processing like excitation contraction coupling. Even in cells 
with disrupted plasma membrane, local contractions were reported. This 
shows the role of calcium waves in contraction (Fabiato and Fabiato, 1975). 
 
Calcium  clock theory and Calcium in diastolic depolarisation 
                  Calcium clock theory states that the local calcium release from the 
sarcoplasmic reticulum activates the sodium calcium exchanger in forward 
mode. The stoichiometry of the sodium calcium exchanger is 1 calcium:3 
sodium. It exchanges one calcium ion out of the cell for 3 sodium ions into the 
cell (Hinata and Kimura, 2004). Thus it produces a net inward current causing 
depolarisation of the cell. This increases the slope of the diastolic 
depolarisation phase resulting in action potential. Thus studies say that 
calcium release from sarcoplasmic reticulum is responsible for diastolic  
 
 
 
depolarisation. The calcium release from sarcoplasmic reticulum can be 
through either Ryanodine receptor or IP3 receptor.  
 
Ryanodine receptor 
                    Ryanodine is a plant alkaloid which is also a specific ligand for a 
large conductance calcium release channel present in the membrane of 
endoplasmic reticulum. Hence those calcium release channels are named as 
Ryanodine receptors. The elementary calcium release events caused by release 
of calcium from single Ryanodine receptor is called „Calcium quarks” and 
from a cluster of Ryanodine receptors is called „Calcium sparks”.  In skeletal 
muscles the Ryanodine receptors are activated following the depolarisation 
mediated activation of the L-type calcium channels. These two channels are 
co-localised in the T-tubule sarcoplasmic junctions and hence the Ryanodine 
receptor in skeletal muscle is voltage gated, where the voltage is sensed by the 
calcium channels. The cardiac Ryanodine receptors are activated by 
intracellular calcium which enters the cell through the calcium channels in the 
plasma membrane. This is called as calcium-induced calcium release (Griffiths 
and MacLeod, 2003). 
                   Ryanodine receptors are tetramers. They have a molecular weight 
of 2.3 million Daltons. There are 3 subtypes of Ryanodine receptors- RyR1, 
RyR2, RyR3. The Ryanodine receptor1 (RyR1) is present in skeletal muscle  
 
 
 
sarcoplasmic reticulum(Marks et al., 1989). The Ryanodine receptor 2 (RyR2) 
is present in cardiac muscle sarcoplasmic reticulum and it has 66% sequence 
identity with RyR1(Nakai et al., 1990).  The third isoform of Ryanodine 
receptor (RyR3) is present in brain. This RyR3 is almost similar to RyR2 
(Hakamata et al., 1992). Ryanodine receptor is the major sarcoplasmic 
calcium release channel present in the cardiac myocytes. Its concentration is 
500 – 1000 fmol/mg of protein in ventricular myocytes in various mammalian 
species (Bers and Stiffel, 1993). This accounts for around 1.5 to 35 million 
Ryanodine receptors in a 30 pl ventricular myocytes (Bers, 2001). 
 
Functional role of Ryanodine receptor:  
                   Ryanodine receptor releases calcium from the sarcoplasmic 
reticulum during systole and thus plays a role in excitation contraction 
coupling (Bers, 2002). Some studies have shown that Ryanodine also releases 
calcium from the sarcoplasmic reticulum in diastole and thereby play a role in 
rhythm generation (Maltsev and Lakatta, 2007). But during diastolic 
depolarisation when the intracellular calcium is low, what causes activation of 
Ryanodine receptor is not known. Some studies show that the calcium entry 
through the T-type calcium channels during the diastolic depolarisation 
activates the Ryanodine receptors (Huser et al., 2000).  
 
 
 
 
IP3 receptor 
                  Evidence from recent studies have shown the important role of IP3 
mediated Calcium release in cytoplasmic and nuclear calcium signalling. In 
1953 a response called „phosphatidylinositol response‟ was discovered by 
Hokin and Hokin and it was widely accepted that binding of some ligands 
cause breaking of the phosphoinositol present in cell membrane and this is 
coupled to increased intracellular calcium release (Hokin M R and Hokin L E, 
1953).  
                The IP3 receptor was discovered by Mikoshiba in 1989. It was 
identified as a ligand activated calcium channel (Furuichi et al., 1989). IP3 
receptor is ubiquitously present in all organisms and in all types of cells. The 
IP3 receptor is found to be localized to the endoplasmic reticulum by 
immunogold method (Otsu et al., 1990). These IP3 receptors change their 
conformation in the presence of calcium. Calcium binding changes the 
conformation of the IP3Receptor from a square shaped closed state to a 
windmill shaped open state (Hamada et al., 2003) and open their pores on 
binding to IP3(Chan et al., 2010).  
 
 
 
Figure 4: IP3 receptor conformational change from the closed square 
shape to the open wind-mill shape by calcium 
 
 
                      There are three isoforms of IP3 receptors (IP3R) namely IP3 R1,  
IP3R2, IP3R3(Furuichi et al., 1994)It has been found that type 1 IP3R are 
dominant in human atrial cardiomyocytes and in rat purkinje myocytes. The 
atrial and ventricular myocytes of most of the species express predominantly 
the Type 2 IP3R and to a lesser extent they express the type3 IP3R (Gorza et 
al., 1993).  
 
                    The different isoforms of IP3Receptors differ in their IP3 binding 
affinities. IP3R2 has the highest binding affinity to IP3, which is followed by 
IP3 R1 and then IP3R3. This difference in  binding affinities of the three 
isoforms to IP3 is due to the suppressor and ligand binding domain interaction 
within the receptor (Iwai et al., 2007). They also differ in activation and  
 
 
inactivation by calcium, phosphorylation and regulation by ATP 
(Bezprozvanny, 2005). 
                 The IP3R1 was cloned from rodent and human T cells(Furuichi et 
al., 1989; Harnick et al., 1995). The second type of IP3 receptor was cloned 
from rat cerebellum and it shares 69%sequence  identity with  IP3R1(Südhof et 
al., 1991). The third type of IP3 receptor was found in pancreatic islets, kidney, 
gastrointestinal tract and other tissues. They have 62% sequence identity with 
IP3R1 and 64% sequence identity with IP3R2 (Blondel et al., 1993). These 
isoforms differ from each other by their IP3 binding affinities. IP3 R2 has high 
affinity towards IP3 binding compared to other isoforms, which is followed by 
IP3R1 and then IP3R3 (Iwai et al., 2007). 
                    The structure of IP3 receptor is homotetrameric or 
heterotetrameric. Type 1 IP3 receptor is a polypeptide made of 2749 amino 
acids. It has five functionally different regions – the amino terminal IP3 
suppressor domain, the IP3 binding domain, the central modulatory domain, 
the carboxy terminal channel domain and the coupling domain(Bosanac et al., 
2005). The IP3 binding core domain is the region of specific IP3 binding. The 
amino  terminal domain with 225 amino acid residues is the suppressor region 
for IP3 binding and deletion of this region increases the affinity of the receptor 
to IP3 binding(Yoshikawa et al., 1996).  
 The IP3 binding core domain has two regions namely the α domain and the β 
domain. In between these two domains is a positively charged pocket where 
 
 
IP3 molecule binds. The 11 amino acid residues in the IP3 binding core domain 
are responsible for IP3 binding and all of them except Gly-268 are maintained 
in all isoforms of IP receptor.  Calcium binding sites are identified in two 
separate locations in IP3 binding core domain(Bosanac et al., 2002). 
 In the amino terminus, the first 220 amino acid residues just before the IP3 
binding region plays a major role in suppression of IP3 binding and in 
interaction of regulatory proteins. The suppression region has a head sub 
domain in the form of β-trefoil and an arm sub domain in the form of helix-
turn-helix. There is a conserved region in the head sub domain which interacts 
with the IP3 binding core domain and also with the binding sites of other 
cellular signalling proteins like calmodulin and thus it communicates with 
these proteins (Bosanac et al., 2005).  
                 With the help of biochemical studies and NMR, it has been found 
that the aromatic residue present in Tyr-167 in IP3 R1 and Trp-168 in IP3R3 is 
responsible for coupling between channel gating and ligand binding (Chan et 
al., 2010). 
 
                   A three dimensional electron microscopic structure of the receptor 
shows a 4-fold symmetry indicating the tetrameric organization of the 
receptor. Two regions are seen in this three dimensional view – one is the 
cytoplasmic portion of the receptor which is larger and another smaller  
 
 
 
transmembrane portion (Bosanac et al., 2002).  All these studies on the 
structure of IP3Receptor have been done on IP3 R1 isoform and IP3R3 isoform.  
 
Activation of IP3R: 
                 Ryanodine receptors require intracellular calcium for its activation. 
Hence they depend on the voltage gated calcium channel activity during every 
action potential (Bers, 2002). 
                 IP3Receptors are activated by both IP3 and calcium (Bootman et al., 
1995). It is understood that binding of IP3R by IP3 ligand helps in activation of 
the receptor by calcium ion (Foskett et al., 2007). During systole the IP3R is 
bound with IP3 and it waits for the calcium to bind and activate the receptor. 
But this IP3 binding to the receptor not only activates the IP3Receptor but also 
increases the sensitivity of the receptor towards calcium. Thus IP3 bound  
receptor can be activated even in the presence of minimal level of  calcium 
like diastolic calcium (Gilbert et al., 1991). This activation of IP3R by diastolic 
calcium levels can be responsible for the pacemaking effects and pro-
arrhythmogenic effects of IP3R (Ter Keurs and Boyden, 2007).  
                   IP3Receptor is ubiquitously present in all organisms and in all 
types of cell. But it is present in a very small number compared to Ryanodine 
receptors which are also present in endoplasmic reticulum and nuclear 
envelope and also has the function of calcium release. Microsomal 
 
 
preparations of hearts of various species showed that Ryanodine  Receptor 
density was 3-4 pmol/mg protein in human ventricle (Nimer et al., 1995) and 
5.5-7pmol/mg protein in dog, mouse, rat and rabbit ventricles (Jeyakumar et 
al., 2001). But the IP3R densities were 0.09pmol/mg protein in bovine 
ventricle (Gorza et al., 1993), 0.35 pmol/mg protein in rat ventricular 
myocytes (P. Lipp et al., 2000) and 0.66 pmol/mg protein in canine ventricular 
myocytes(Kijima and Fleischer, 1992). This shows the ratio of IP3R to 
Ryanodine receptor to be 1:100(Bootman et al., 2009). 
                   The major IP3 sensitive intracellular site of Calcium store is 
endoplasmic reticulum. But studies have shown that IP3 can release calcium 
from other non-endoplasmic reticular stores like golgi bodies and nuclear 
envelope (Rizzuto and Pozzan, 2006). In some cells like B lymphocytes,  IP3 
receptor is present in the plasma membrane and it gates the calcium influx 
from the extracellular fluid (Vazquez et al., 2002) . 
INOSITOL 1,4,5-TRIPHOSPHATE: 
 
Figure 5:  Structure of an IP3 molecule 
 
 
 
IP3 is produced by the stimulation of plasma membrane receptors which are 
bound to G proteins – Gq. The stimulation of these receptors activates Gq 
which in turn activates the membrane bound enzyme called Phospholipase C 
(PLC). Phospholipase C hydrolyses Phosphatidylinositol 4,5-bisphosphate 
(PIP2) into IP3 and DAG (Diacyl glycerol). PIP2 is a minor phospholipid 
present in the plasma membrane. But it is the major form of 
polyphosphoinositide present in the plasma membrane. The concentration of 
PIP2 in cardiomyocyte plasma membrane is around 10-30 µM or 150-450 
pmol/mg of protein (Nasuhoglu et al., 2002). PIP2 itself acts as an important 
signalling structure for regulation of ion channels and transporters like Plasma 
membrane calcium ATPase (PMCA), Sodium calcium exchanger (NCX) and 
epithelial Sodium channels (ENaC). It also helps in anchoring cytoskeletal 
proteins with the membrane (Hilgemann et al., 2001). PIP2 is the precursor of 
PIP3 which is also involved in cell signalling. 
 
 
 
 
Figure 6 : Mechanism of IP3 production from PIP2 
 
                  There are at least 13 different isoforms of PLC which are grouped 
into 6 subfamilies: β, δ, ε, ε, γ and δ. Of these subfamilies, β, γ, δ and ε are 
present in cardiomyocytes. PLC can be activated by various factors such as: 
Ras which activates PLCε, PIP2 and calcium which activates PLCδ, receptor 
tyrosine kinase which activates PLCγ and heptahelical G protein coupled 
receptor which activates PLCβ (Rhee, 2001). Thus various factors like 
hormones, neurotransmitters and stimuli like stretch can act on their receptors 
and activate PLC and cause an increase in IP3 concentration.   Many studies 
have been done to study the kinetics of IP3 turnover. These studies show that 
stimulation of cardiomyocytes with endothelin causes a rise in IP3 
concentration from around 15nM to 35nM in 400ms. This increase in 
 
 
IP3concentration then gradually comes back to baseline within ten minutes 
(Cooling et al., 2007). 
 
                   Among the two products produced by the hydrolysis of PIP2, IP3 
is hydrophilic. Hence it enters the cytoplasm and goes and binds to its receptor 
present in the endoplasmic reticulum. DAG is insoluble, so remains attached 
to the membrane and activates the enzyme Protein Kinase C (PKC) and is 
involved in some signal processing.  
 
Involvement in different process in different tissues 
 IP3is involved in antigen specific T lymphocyte activation: 
                 Cell mediated immunity acts through T lymphocytes. It is a very 
important defence mechanism of our body against pathogens like virus. The 
antigen is presented to the T cell by APC (antigen presenting cells). When the 
T cells come in contact with this antigen it gets activated. Antigen specific 
activation of T lymphocytes occurs when the T Cell Receptor (TCR) binds 
with the antigen. This TCR activates tyrosine kinase which in turn activates 
Phospholipase C (PLC) present in the cell membrane. PLC acts on PIP2 to 
produce IP3 and DAG. This IP3 goes and binds to its receptor present in the 
endoplasmic reticulum and releases calcium. This increase in intracellular 
calcium causes transcriptional activation of Interleukin 2 which is a T cell 
 
 
growth factor(Jayaraman et al., 1995). Thus IP3 is involved in activation of T 
cell and hence in immunity. 
 
 
 IP3 is involved in apoptosis caused by various stimuli: 
 
                     Apoptosis is programmed cell death. The thymocytes undergo 
apoptosis by glucocorticoids, irradiation, antibodies to CD3 and removal of 
certain growth factors. All these factors cause increase in calcium 
concentration and this increase in calcium activates endonuclease which 
cleaves the DNA fragments causing apoptosis. Studies have shown that 
thapsigargine which inhibits SERCA (sarco endoplasmic reticulum calcium 
ATPase) can initiate apoptosis(Jiang et al., 1994) and chelation of intracellular 
calcium can prevent apoptosis(Story et al., 1992). These results confirm the 
role of intracellular calcium in apoptosis. The T cells lacking IP3R1 were 
resistant to apoptosis (Jayaraman and Marks, 1997). This shows that IP3 
induced increase in intracellular calcium is essential for apoptosis. 
 
 
 IP3 and SOC:   
                   When IP3 induced calcium release depletes the store, this 
depletion of store opens up a channel in the plasma membrane to allow influx 
 
 
of calcium and refill the stores. This process was first proposed by Putney in 
1986 and later he named it as Store operated Calcium Entry (SOCE)(Putney, 
1990, 1986). The current through this SOC was first best described in mast 
cells by Hoth and Penner as a highly calcium selective, inward rectifying 
current and not voltage selective (Hoth and Penner, 1992). They named it as 
Calcium Release Activated Calcium Current (CRAC). Ever since many SOC 
currents which are less calcium selective and even completely non-selective 
calcium entry have been described in many other cells. Studies have found 
that this CRAC current has two components. One is through the molecular 
structure of SOC: Orai1 present in the plasma membrane together with the 
calcium sensor STIM1 present in endoplasmic reticulum. Another feature of 
CRAC channel is the conformational coupling between the IP3 receptor 
present in the endoplasmic reticulum and the TRPC1 channel present in the 
plasma membrane. This conformational coupling is similar to the one seen 
between voltage gated calcium channels and Ryanodine receptors seen in 
skeletal muscles.  
 
 IP3 in cardiovascular system:  
                  IP3 mediated calcium release from the endoplasmic reticulum plays 
a major role in pharmaco-mechanical coupling in the smooth muscles of the 
blood vessels. Thus they are important in maintaining the vessel tone and 
thereby the blood pressure. 
 
 
 IP3 in heart 
                    All three isoforms of IP3 receptors are found in isolated atrial and 
ventricular cardiomyocytes. Among these three isoforms, Type II isoform is 
most predominant in cardiomyocytes (P Lipp et al., 2000). The atrial 
cardiomyocytes show a six fold higher expression of IP3R compared to the 
ventricular cardiomyocytes (P Lipp et al., 2000). 
 
IP3 involvement in other effects in heart: 
o Role of IP3 in excitation transcription coupling in atrial and 
ventricular myocytes: 
                 Nuclear calcium dynamics is different from the cytoplasmic 
calcium dynamics. This is because of the presence of a nuclear envelope 
present around the nucleus. This nuclear envelope has an inner nuclear 
membrane and an outer nuclear membrane with a space between them. This 
nuclear envelope is contiguous with the sarco-endoplasmic reticulum. The 
double layered nuclear envelope fuses at many places to form pores. These 
pores have structures called nuclear pore complex (NPC). These pores acts as 
a portal for the movement of ions like calcium between the cytoplasm and 
nucleoplasm (Wu et al., 2006). Similar to sarco-endoplasmic reticulum, the 
nuclear envelope also has many calcium handling and ion transporting 
proteins like the Ryanodine receptor type 1, Sodium calcium exchanger,  
 
 
sodium potassium ATPase and sodium proton exchanger. The calcium pump 
SERCA is not present in the nuclear envelope (Wu et al., 2006; Zima and 
Blatter, 2004).  Studies have shown the presence of IP3R in the nuclear 
envelope. Also studies have shown a depletion of nuclear calcium on 
stimulation of these IP3 receptors in the nuclear envelope (Wu et al., 2006). 
The change in the local nuclear calcium kinetics can activate many 
transcription factors. Thus IP3 is found to be responsible for the regulation of 
nuclear calcium released from peri-nuclear stores in both atrial and ventricular 
myocytes and therefore responsible for regulation of gene transcription 
(Kockskämper et al., 2008a). This  regulation of gene transcription by nuclear 
calcium is called as excitation-transcription coupling (Wu et al., 2006). 
 
₋ Role of IP3 in ECC in atrial and ventricular myocytes: 
                   In cardiac myocytes ECC is a process of action potential mediated 
activation of voltage gated calcium channels present in the plasma membrane, 
which in turn activates calcium induced calcium release (CICR) from the 
sarcoplasmic reticulum. This increases the cytosolic calcium and causes 
muscle contraction (Bers, 2001). IP3 receptors are present in both atrial and 
ventricular cardiomyocytes. Atrial myocytes express more density of IP3R 
compared to the ventricular receptors (Zima and Blatter, 2004).  The  
 
 
 
predominant form of IP3R expressed in cardiomyocytes is type 2 IP3R.  Their 
channel activity is dependent on intracellular IP3 concentration and 
intracellular calcium concentration (Michell et al., 1981). Many studies have  
shown the role of intracellular IP3 in modulating the cytosolic calcium 
transients in both atrial and ventricular cardiomyocytes. IP3 produces increase 
in intracellular calcium by releasing calcium from the endoplasmic reticulum. 
But the quantum of calcium release by IP3 R is very small compared to 
Ryanodine receptor and also the number of IP3R is less compared to that of 
Ryanodine receptor (Bootman et al., 2009). The role of Ryanodine receptor in 
the ECC is a well established fact. But the role of IP3R in ECC has been a 
controversy. But studies have shown that IP3R has a role in ECC. In 
permeabilised rat ventricular myocytes, application of IP3 increased the 
frequency of calcium sparks to 21% suggesting the role of IP3 in positive 
inotropic effect in heart (Zima and Blatter, 2004). 
The IP3R are present co-localised with the Ryanodine receptors in the sub-
sarcolemmal space in the cardiomyocytes (P Lipp et al., 2000). Activation of 
IP3 R by membrane permeable IP3 ester showed seven fold increase in number 
of spontaneous calcium sparks in rat cardiomyocytes. Thus the small eventless 
calcium release from IP3R can activate the Ryanodine receptor and can 
modulate the excitation contraction coupling in heart (P. Lipp et al., 2000). 
 
 
 
 
Other studies have shown that endothelin is strongly cardiotonic and it acts by 
stimulating the production of IP3 and mobilising the intracellular stores(Vigne 
et al., 1989). Also Histamine acts through the H1 receptor and exerts a positive 
inotropic effect. This was studied in guinea pig left atrium and it was found 
that the positive inotropic effect was through increase in IP3 production 
(Sakuma et al., 1988). 
 
o IP3 receptor in developing cardiomyocytes: 
                 One of the first organs found to develop in an embryo is the heart. 
As heart develops, the embryo acquire the ability to produce spontaneous 
rhythmic calcium signals and to contract. Many studies done in either prenatal 
cells or ESdCs (Embryonic Stem cell derived Cardiomyocytes) have shown 
that IP3 receptors have a significant role in the pacemaking activity and 
thereby cardiogenesis. The spontaneous calcium oscillations start as soon as 
the heart tube is formed. This drives  contraction, necessary gene transcription 
and regulation of structural arrangement of the cardiomyocytes (Fu et al., 
2006). Hence inhibition of these calcium oscillations can prevent the 
development of heart (Pucéat and Jaconi, 2005). 
                 Type 2 Ryanodine receptor is responsible for the calcium 
oscillations seen in the adult cardiomyocytes and neonatal cardiomyocytes. 
Studies have shown that at day 10 of embryonic life (E10) mice deficient of  
 
 
type 2 Ryanodine receptor die with cardiac defects because of immature 
excitation contraction coupling (Takeshima et al., 1998). However some 
calcium oscillations are seen in this Ryanodine receptor deficient mice as early 
as E 5-9.5  (Takeshima et al., 1998)and these oscillations were insensitive to 
inhibition of voltage gated calcium channels or NCX (sodium calcium 
exchanger), but were affected by depletion of internal stored calcium (Sasse et 
al., 2007). Thus indicating that in embryonic cardiomyocytes there is periodic 
release of calcium from sarcoplasmic reticulum which is not through 
Ryanodine receptor. 
                  Many studies show that IP3 receptors have a role in these calcium 
oscillations seen in early embryonic stage of cardiomyocytes. For example, a 
study has shown that the calcium oscillations seen in rat embryonic cells were 
sensitive to  2-APB (2-aminoethoxy diphenyl borate) which is an IP3 receptor 
blocker (Sasse et al., 2007). Another study has shown that IP3 receptors are 
expressed in early embryonic cells as early as day 5 in contrast to Ryanodine 
receptor which is not expressed until day 8.5 or later (Rosemblit et al., 1999). 
These data show that IP3 receptors are much earlier expressed than the 
Ryanodine receptors in embryonic cardiomyocytes and their timing of 
expression correlates with the onset of periodic calcium oscillations seen in 
these cells. 
 
 
 
                   Embryonic stem cell derived cardiomyocytes are used to study the 
cardiac development because of its ease of availability and genetic 
manipulation compared to the pre-natal cells (Banach et al., 2003). Studies 
using embryonic stem cell derived cardiomyocytes have shown that in these 
cells IP3 receptors are expressed during proliferating stage and during 
differentiation stage (Kolossov et al., 1998). Also these cells start showing 
spontaneous rhythmic calcium oscillations and contractions even before they 
are terminally differentiated. Usually the mechanism for spontaneous calcium 
oscillations in adult cell is the HCN (hyperpolarisation activated cyclic 
nucleotide gated channel) channel mediated current (Yasui et al., 2001). 
However the spontaneous calcium oscillations are seen even earlier than the 
appearance of HCN mediated current and they are not affected by If inhibitors 
(Méry et al., 2005). Also these calcium oscillations are not affected by 
complete depolarisation, implying that membrane potential oscillations are not 
responsible for these spontaneous calcium oscillations (Viatchenko-Karpinski 
et al., 1999). But when these embryonic stem cell derived cardiomyocytes 
were transfected with antisense DNA  against IP3 receptor type 1 or when IP3 
receptor antagonist were applied there was significant reduction of the 
spontaneous calcium oscillations and contractions (Mery et al., 
2005).Stimulation of IP3 production had positive chronotropic effect in these 
embryonic stem cell derived cardiomyocytes (Kapur and Banach, 2007).  
 
 
 
But these effects diminished as the cells differentiated suggesting that as these 
cells differentiated, the calcium handling is regulated by other mechanisms 
also (Fu et al., 2006). But IP3 receptor is not completely lost. They are found 
in neo natal rats cardiomyocytes (Luo et al., 2008) and they are expressed till 
adult cells. 
 
 Role of IP3in pathological conditions of heart: 
o Role of IP3 in arrhythmia: 
                   Studies have shown the role of IP3R in arrhythmia. Atrial 
fibrillation is the most common arrhythmia found in clinical settings. The 
main mechanism behind arrhythmia is abnormal cytosolic calcium 
oscillations. The intracellular calcium oscillation is maintained by two 
important receptors present in the endoplasmic reticulum. They are Ryanodine 
receptors and IP3R. The incidence of atrial fibrillation increases with age and 
also the expression of IP3 receptors increases with age in heart (Cao et al., 
2002). Studies have shown that there is increased expression of IP3R in the 
atrial tissues of patients with chronic atrial fibrillation (Yamada et al., 2001). 
Thus up-regulated IP3R can modulate intracellular calcium homeostasis and 
produce a delayed after depolarization leading to arrhythmia in heart (Zima 
and Blatter, 2004). Also studies have shown that IP3 deficient rats are 
protected from pro-arrhythmogenic stress (Li et al., 2005). Also the levels of  
 
 
 
endothelin and angiotensin II are also increased in cardiac tissues with atrial 
fibrillation (Zerkowski et al., 1993). Both these are known to act by increasing 
IP3 levels and produce arrhythmia in isolated human atrial tissues. Thus 
angiotensin II and endothelin mediated increase in IP3 levels may be 
responsible for atrial fibrillation. Several studies have shown that ACE 
inhibitors and AT1 receptor blockers can reduce the incidence of developing 
atrial fibrillation in patients at risk (Ehrlich et al., 2006). 
 
o  Arrhythmia related to Ankyrin-B mutation:   
                   Ankyrin-B is an adaptor protein molecule with molecular weight 
of 220 kDa. It is responsible for the post translational stability and also for 
targeting the IP3 receptor to the sarcoplasmic reticulum near the junction of T-
tubules (Mohler et al., 2004a). Mutation leading to lack of Ankyrin-B causes 
decrease in IP3 receptor in the sarcoplasmic reticulum- T-tubule junctions and 
are associated with arrhythmias (Mohler et al., 2004b).  When IP3 receptors 
are absent as seen in mutation of Ankyrin-B, there is increase in sarcoplasmic 
reticulum calcium load. This causes activation of Ryanodine receptors and 
produce arrhythmia (Mohler et al., 2003). Thus both activation of IP3 receptor 
and loss-of-function mutation of IP3 receptor is responsible for the 
development of arrhythmia. 
 
 
 
 
o IP3 is also found to be responsible for the hypertrophy of 
cardiomyocytes.  
                  Endothelin is an endothelium derived vaso-constricting agent. It 
is produced by aortic endothelial cells and acts on cardiac myocytes. This 
endothelin is found to increase MLC2,alpha-actin and troponin I which are 
the muscle specific genes involved in hypertrophy of cultured neonatal rat 
cardiomyocytes(Ito et al., 1991) and this endothelin is found to act through 
IP3(Ito et al., 1991; Kockskämper et al., 2008b) 
 
o Reperfusion arrhythmia:  
                   Reperfusion of heart after a period of ischemia produces 
arrhythmias and even sudden cardiac death. During reperfusion followed 
by ischemia there is increase in IP3 concentration in the cardiac myocytes 
(Jacobsen et al., 1996). This is because of increased release of 
norepinephrine (NE) from the sympathetic nerves within the heart which 
stimulate a lot of α-adrenergic receptors and produce increased 
concentration of IP3. This increased concentration of IP3 is responsible for 
arrhythmia, ventricular tachycardia and even ventricular fibrillation 
(Woodcock et al., 2000). Studies have shown that agents that prevent IP3 
generation can prevent these reperfusion arrhythmias (Du et al., 1995). 
 
 
 
 
o Diabetic cardiomyopathy: 
              Altered calcium homeostasis is seen in diabetic cardiomyocytes. 
The calcium transients are reduced and prolonged in these cells. This is 
because of the changes seen in calcium handling proteins in diabetic 
cardiomyopathy like: reduced expression of SERCA, Ryanodine receptors 
and sodium calcium exchangers, increased expression of phospholamban 
and IP3 receptors. As a result the sarcoplasmic calcium release and 
reuptake is altered (Choi et al., 2002). Studies have shown that Insulin 
increases IP3 concentration and triggers arrhythmia in diabetic mice 
(Fauconnier et al., 2005). Also the levels of PIP2 and activity of PLC 
enzyme are reduced (Tappia et al., 2004). Taken together, altered IP3 
generation and IP3-induced sarcoplasmic calcium release contributes to the 
arrhythmias seen in diabetic cardiomyopathy. 
 
o Heart Failure:  
                   Heart failure is associated with activation of sympathetic 
nervous system, endothelin system and rennin-angiotensin system. The 
levels of noeepinephrine, Angiotensin II and Endothelin are elevated in 
cardiac tissue in heart failure and also their receptors expression is also 
altered. Expression of α1-adrenergic receptor is not changed but there is 
decreased expression of β1-adrenergic receptors leading to a relative 
increase in α1-adrenergic receptor (Bristow et al., 1988). The angiotensin 
 
 
receptor- AT1 is down regulated (Regitz-Zagrosek et al., 1998) and the 
endothelin receptor-ETA is up-regulated (Pieske et al., 1999; Zolk et al., 
1999). Also there is increased activation of PLC enzyme and PIP2 
metabolism and therefore increased IP3 concentration in heart failure. Also 
the IP3 receptor expression is increased in both human and animal model of 
heart failure (Tappia et al., 1999; Ziegelhoffer et al., 2001). The Ryanodine 
receptor expression is decreased (Ai et al., 2005). Thus all these data 
suggest that IP3mediated calcium release is responsible for the 
development and progress of the disease in heart failure. 
 
 IP3 in Chronotropy 
 
                    The heart beat is initiated in a specialised group of cells called 
pacemaker cells. These pacemaker cells in adult heart are found to have high 
expression of pacemaker channels known as HCN (hyperpolarisation activated 
cyclic nucleotide gated channels) channels(Accili et al., 2002). The cell 
contractions and rhythmic calcium oscillations are seen as early as 7th day of 
embryonic life(Porter and Rivkees, 2001). But in this early embryonic stage 
there is less expression of HCN channels(Stieber et al., 2003). Studies have 
shown that in these early stages of embryonic life, the calcium oscillations and 
the cell contractions are through rhythmic shunting of calcium in and out of 
the endoplasmic reticulum.  This was confirmed by studies where calreticulin 
 
 
decreased pacemaking by buffering the endoplasmic reticular calcium leading 
to decreased release of calcium from endoplasmic reticulum (Méry et al., 
2005). The calcium oscillations from endoplasmic reticulum was mediated 
through IP3R, as addition of IP3 antibody or Xestospongin C (an IP3 receptor 
blocker) also affects the pacemaking activity in these early embryonic 
cells(Méry et al., 2005). This IP3 mediated rhythmic calcium oscillations from 
endoplasmic reticulum is essential for pacemaker activity in early 
cardiogenesis and foetal life.  
                   A study in neonatal rat cardiomyocytes isolated from hearts of 2 to 
5 day old rats, showed an IP3 mediated increase in chronotropy by the action 
of Stromal cell derived factor-1α (SDF-1α) which is a chemokine acting on 
CXCR4 receptor. This receptor is a G protein coupled receptor, hence 
activates PLC and increases the production of IP3. This increase in 
chronotropy was shown as increase in cell beating frequency. The increase in 
cell beating frequency and increase in calcium transient measured by calcium 
imaging by SDF-1α were sensitive to 2-APB which is an IP3 antagonist. Thus 
showing that IP3 has a positive chronotropic effect in neonatal rat 
cardiomyocytes. (Hadad et al., 2013) 
                 The role of IP3 in chronotropy of heart has been shown in a study 
on embryonic stem cell derived cardiomyocytes (ESdCs) which are used in 
cardiac replacement therapy. Spontaneous calcium transients were found in 
the day 9 cells at the onset of beating and these were dependent on L type  
 
 
calcium channels. But the calcium transients found on day 16 were dependent 
on Calcium induced calcium release (CICR). Similarly calcium extrusions in 
day 9 cells were predominantly by sodium calcium exchanger (NCX) and in 
day 16 cells were mostly by SERCA. Also the calcium transients were 
suppressed by IP3 receptor blocker and by PLC inhibitor, but not with 
caffeine. This shows that the calcium transients responsible for the beating of 
cells were IP3 dependent. Thus the study shows that there is developmental 
change in calcium handling mechanisms and IP3R has a role in chronotropy of 
heart in ESdCs (Kapur and Banach, 2007). 
 
Tools for studying cardiomyocytes IP3 signalling: 
                  Many tools have been used to study the IP3 signalling in 
cardiomyocytes. They are: a) by measuring intracellular IP3 levels b) by 
pharmacological manipulation of IP3 generation, degradation of IP3 receptors 
and c) by genetic manipulation of the IP3 cascade and producing a transgenic 
animal model. 
a) The method of studying IP3 signalling by measuring IP3 levels has been of 
great interest for many years. It is done by analysing the whole cell extracts 
by various methods like mass spectrometry, gas chromatography or ion 
exchange chromatography (Dean and Beaven, 1989). These methods 
cannot be used to study the spatio-temporal organisation of the IP3 
 
 
 
signalling system inside the cell. New florescent probes are also used to 
study the IP3 dynamics. Example for this type of fluorescent probe is 
„LIBRA‟ – a biosensor derived from IP3 binding site of type-3 IP3 receptor 
(Tanimura et al., 2004). A recent study shows the use of a new biosensor 
which can measure intracellular IP3 with temporal and spatial resolution. 
These sensors are called FIRE-1 and FIRE-3 (Fluorescent IP3 responsible 
Element Type 1 and 3). These biosensors are promising tools for studying 
IP3 dynamics with high spatio-temporal resolution in a living cell, but it 
can buffer some IP3 which has to be taken into account (Remus et al., 
2006). 
 
b) Pharmacological manipulation of IP3 signalling cascade is a more 
conventionally used method to study IP3 signalling. The commonly used 
pharmacological agents are blockers of IP3 formation and they act by 
blocking PLC (Neomycin, the PLC inhibitor U73122), IP3 receptor blocker 
or antagonist (Heparin, 2-aminoethoxy diphenyl borate [2-
APB],xestospongins, curcumin). Like all other pharmacological agents 
these also lack specificity. They have other intercellular targets and many 
other unwanted side effects. Some lack membrane permeability (Taylor 
and Broad, 1998). Recently there is development of the membrane 
permeable form of IP3 agonist (Thomas et al., 2000). Also the caged IP3 
 
 
released on photolysis has become a very good tool in studying IP3 
dynamics (Li et al., 1998). 
 
c) The other method of studying cardiac IP3 function is the molecular 
technique. In this method the IP3 signalling cascade is altered genetically 
and transgenic animals are developed. Example for this method of study is 
using an adenoviral mediated IP3 affinity trap which is also known as an 
IP3 sponge (Domeier et al., 2008). It has been used to abolish all the IP3 
mediated response similar to pharmacological IP3R blocker. Another study 
gives an even better tool than the IP3 sponge. The study shows the usage of 
IP3 metabolising enzyme called IP35‟phosphatase. This has an advantage 
that it need not be present in 1:1 stoichiometry to completely abolish IP3 
activity. A recent study show that the endothelin mediated positive 
inotropic and pro-arrhythmic effects were completely absent in transgenic 
mouse atrial myocytes lacking Type 2 IP3R. This effect of endothelin was 
specific to IP3R because a normal inotropic response to β- adrenergic 
stimulation was seen in these transgenic mouse cells (Li et al., 2005). 
 
 
 
 
 
 
 
 Phenylephrine: 
 
 
Figure 7: Structure of a Phenylephrine molecule 
 
                  Phenylephrine is a selective α1 adrenergic receptor agonist. The α1 
adrenergic receptor is a G-protein coupled receptor which is associated with 
the Gq type of G-protein. On activation of this receptor Gq gets activated 
which in turn activates Phospholipase C (PLC) which is a membrane bound 
enzyme. This activated PLC hydrolysis PIP2 to IP3 and DAG and further 
activates protein kinase C (PKC). Thus α1 adrenergic receptor acts by 
increasing the concentration of IP3 and activating PKC. α1 adrenergic 
receptors are abundantly found in vascular smooth muscle. They are also 
found in other sites like gastrointestinal and urinary sphincters, dilator muscle 
of iris and arrectorpili of hair follicles. Hence Phenylephrine which is an 
agonist of this α1 adrenergic receptor produces vasoconstriction, dilatation of 
pupil and increased tone of urinary and gastrointestinal sphincters. 
 
 
 
 Phenylephrine in heart: 
                      It is known that catecholamine exert their effect on heart through 
beta adrenergic receptors and cause a positive inotropic effect. But heart also 
has alpha adrenergic receptors and studies have shown that alpha adrenergic 
agonist also cause increase in force of contraction in heart (Scholz et al., 
1986). The mechanism of action of alpha adrenergic agonist -Phenylephrine 
was studied in left auricular tissues of rat heart and it was found to have a 
positive inotropic effect  by increasing the concentration of IP3(Scholz et al., 
1988). 
 
Figure 8: Mechanism of action of Phenylephrine. (P-Phenylephrine; PLC- 
Phospholipase C; PIP2- Phosphoinositol bisphosphate; DAG- Diacyl 
glycerol; IP3- Inositol 1,4,5-triphosphate; IP3R- IP3 receptor) 
 
 
Neomycin  
 
 
Figure 9 : Structure of a Neomycin molecule 
 
                     Neomycin is an aminoglycoside antibiotic. It was discovered in 
1949 by an American microbiologist Selman Waksman and his student Hubert 
Lechevalier. It is produced naturally from an actinobacteria, Streptomyces 
fradiae. Neomycin is active against both gram positive and gram negative 
bacteria. It binds with the 30s ribosome of the organism and interferes with 
mRNA binding and produces non-functional or toxic proteins which destroys 
the organism. It also blocks the action of Phospholipase C and thus decreases 
production of IP3 and affects intracellular calcium signalling (Walz et al., 
2000). Neomycin also non-selectively inhibits the L,N and Q type of calcium 
channels and inhibits the neuronal response mediated by these channels (Keith 
et al., 1992) and causes depression of neuromuscular functions (Pittinger and 
Adamson, 1972). Neomycin used as antibiotic has side effect of ototoxicity 
and nephrotoxicity. These toxicities are due to the binding of this antibiotic to  
 
 
membrane phospholipids and inhibition of polyphosphoinositide turnover 
(Lodhi et al., 1979; Schacht, 1976) 
 
 Neomycin and IP3 
                    Neomycin is a polyvalent cation. It gets attached to the 
phosphatidyl inositol present in the cell membrane (Gabev et al., 1989). This 
attachment of Neomycin to phosphatidylinositol prevents the action of 
Phospholipase C (PLC). So PLC cannot produce IP3  and DAG from PIP2, 
leading to decrease in IP3 production(Marche et al., 1987). Thus Neomycin 
acts as an IP3antagonist and is used in experiments to block the effect of IP3. 
 
Rat experiments: 
                    Animal research has played a most important role in every 
medical breakthrough. Nearly every scientist who got Nobel Prize since 1901 
for Physiology and Medicine has relied on animal experiments for their 
research. Animals are very similar to human beings in organ system and its 
function. Animals suffer from diseases like TB, asthma, flu etc which are 
similar to those in humans.  Also many medicines like antibiotics and 
painkillers are the same for animals and human beings. Hence it is very useful 
to use animals for experiments and research. Human share around 95% of 
their gene with a mouse, thus making mouse a very effective model for human 
 
 
body and disease condition. Hence more than 95% of animal experiments are 
done on rats and mouse. Other animals like dogs, cats, primates, birds, fish 
and some invertebrates are also used for experiments.  
                Rats are the most commonly used animal because of their 
availability, small size, ease of handling, low cost and fast reproduction rate. 
Developing genetic models and knockout model in rat is difficult compared to 
mouse. But rats are good models for drug testing.  
 
Isolated heart study 
                The perfused isolated hearts from animals are extensively used for 
metabolic and hemodynamic studies. It is a predominant in vitro technique 
used in physiological and pharmacological research. The isolated perfused 
heart studies are useful in studying the intrinsic properties of heart like 
contractility, automaticity and conductivity without the neuro-humoral 
interference seen in an intact animal. 
 
 Langendorff setup 
                    The technique for studying isolated heart was first described by 
Oscar Langendorff in 1985(Langendorff, 1895). This technique of 
Langendorff has been modified and widely used for isolated heart studies ever  
 
 
 
since. It is usefully to study the isolated heart of homeothermic animals with 
coronary arteries. Homeothermic animals are also called as warm blooded 
animals in which the internal body temperature is maintained constant 
regardless of the external temperature. In animals like frog where there is no 
coronary perfusion this setup is not required. The hearts of frog and fishes take 
oxygen and nutrients by diffusion through the numerous pores present in their 
cardiac musculature. The principle of this Langendorff setup is to perfuse the 
heart with a solution containing all substrates, nutrients and oxygen through a 
cannula inserted into the ascending aorta. The pressure of the flow of perfusate 
will keep the aortic valves closed and therefore the perfusate will flow through 
the open coronary ostium present in the base of aorta and will enter into the 
coronary system. This technique has been used in basic cardiovascular 
research for studying the basic properties of heart like inotropy and 
chronotropy, for obtaining individual cardiomyocytes by enzymatic digestion 
and for testing various drugs on isolated heart. 
                   This study aims at finding the role of calcium release through IP3 
from the sarcoplasmic reticulum during the diastolic depolarisation and thus 
the effect of IP3on heart rate. For this isolated perfused hearts of Wistar rats 
have been used in Langendorff mode and heart rate was calculated from the 
ECG recorded using surface electrodes. Phenylephrine and Neomycin were 
used to alter the IP3 dynamics. 
 
 
 
 
 
 
 
 
AIMS AND 
OBJECTIVES 
 
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES: 
 
Aim:  
To study the role of Inositol 1,4,5-triphosphate (IP3) in rhythm generation in 
isolated Wistar rat hearts. 
 
Objectives:  
1) To study the changes in heart rate in an isolated rat heart perfused with 
normal extracellular solution on  addition of  Phenylephrine (IP3 
agonist) and 
2) To test whether those changes in heart rate by Phenylephrine can be 
blocked by Neomycin, an IP3 antagonist. 
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METHODS 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS: 
 
MATERIALS AND SOLUTIONS USED: 
 
1. Langendorff perfusion setup 
2. MasterFlex Peristaltic Pump 
3. EQUIBATH Circulating Water Bath 
4. Oxygen Supply 
5. CMCdaq Data Acquisition Device 
6. Perfusing Solution – Normal Extracellular Solution 
7. Drugs -    Ketamine 
- Phenylephrine 
- Neomycin 
 
 
 
 
 
 
 
 
SOLUTION PREPARATION: 
                        Normal Extracellular solution was used to perfuse the isolated 
heart in the Langendorff setup. This Normal Extracellular solution had all the 
electrolytes, glucose and pH similar to the extracellular fluid.  
                         For the preparation of solution, the amount of salts needed to 
be added in one litre of Normal Extracellular Solution was calculated and 
weighed accurately using an electronic balance (Precisa XB 320M). This was 
added to one litre of distilled water and thoroughly mixed and dissolved using 
a magnetic stirrer. The solution was prepared freshly and used for all the 
experiments. 
                          After all the salts were added and mixed thoroughly using the 
magnetic stirrer, the pH of the solution was checked using an electronic pH 
meter(METTLER TOLEDO MP220 pH meter). First the pH meter was 
calibrated using known pH solutions of 7.0 and 9.2. Then the pH of the 
solution was checked and was adjusted to 7.4 using 1 molar NaOH solution. 
 
 
 
 
 
 
 
COMPOSITION OF NORMAL EXTRACELLULAR SOLUTION: 
 
 
 
 
 
STOCK SOLUTIONS OF DRUGS: 
 
                   The stock solutions of each of the drugs used were prepared and 
stored. The stock solutions were prepared with thousand times concentration 
than the required concentration in the experiment.  
 
                   Phenylephrine (MW-203.67) stock solution was prepared by 
mixing 20.367 mg of salt in 10ml of distilled water. This makes a stock of 
10mM. This was stored in the freezer at -20 degree Celsius. From this stock 
solution 150µl was taken and added to 150ml of Normal extracellular solution 
during the experiment. This will dilute it thousand times to give a required 
concentration of 10µM in the experiment. 
 
                     Neomycin (MW-908.88) stock was prepared by mixing 18.17 g 
of salt in 10ml of distilled water. This 2M stock was prepared and stored in 
refrigerator at 4 degree Celsius until use to maintain its efficiency. From this 
stock solution 150µl was added to 150ml of Normal extracellular solution 
during the experiment to make it to a concentration of 2 mM. 
 
 
 
The salts used in the preparation of Normal extracellular solution were 
purchased from the following companies: 
 
1. Sodium chloride : Sigma-Aldrich 
2. Potassium chloride :  Sigma-Aldrich 
3. Magnesium chloride : Sigma-Aldrich 
4. Calcium chloride : Sigma-Aldrich 
5. Disodium hydrogen phosphate : Qualigens 
6. Glucose : Sigma-Aldrich 
7. HEPES : Lobachemi 
8. Sodium hydroxide : Merck 
 
Drugs: 
1. Phenylephrine : Sigma-Aldrich 
2. Neomycin : Sigma-Aldrich 
 
All these salts and drugs were stored at appropriate conditions as mentioned in 
their data sheets and they were used within their expiry date. 
 
 
 
 
 
LANGENDORFF SETUP: 
                The technique for studying isolated heart was first described by 
Oscar Langendorff in 1985 (Langendorff, 1895). This technique of 
Langendorff has been modified and widely used for isolated heart studies ever 
since. It is useful to study the isolated heart of homeothermic animals with 
coronary arteries.  In animals like frog where there is no coronary perfusion 
this setup is not required. The principle of this Langendorff setup is to perfuse 
the heart with a solution containing all substrates, nutrients and oxygen 
through a cannula inserted into the ascending aorta. The pressure of the flow 
of perfusate will keep the aortic valves closed and therefore the perfusate will 
flow through the open coronary ostium present in the base of aorta and will 
enter into the coronary system.  
                   This technique has been used in basic cardiovascular research for 
studying the basic properties of heart like inotropy and chronotropy, for 
obtaining individual cardiomyocytes by enzymatic digestion and for testing 
various drugs on isolated heart. 
                  The Langendorff setup used in this study included two graduated 
reservoirs and one bubble trap for continuous perfusion. All these reservoirs 
and the bubble trap were maintained at constant temperature of 37 degree 
Celsius using a water bath and the perfusion solution was oxygenated 
continuously. 
 
 
 
                 Figure 10 : Langendorff Perfusion Setup 
PERFUSION 
                  The perfusion of the solution was done at a constant rate of 10ml 
per minute using a Master Flex peristaltic pump. This rate of perfusion gives a 
perfusion pressure of 60mm of Hg which is needed to perfuse the coronaries. 
                                 
Figure 11 : Peristaltic Pump 
 
 
OXYGENATION: 
               The perfusion solution was continuously oxygenated with 100% 
oxygen from an oxygen cylinder connected to the reservoir. The oxygenation 
was at a high flow rate and it was maintained throughout the experiment.  
TEMPERATURE MAINTENANCE: 
              The perfusing solution was maintained and perfused at constant 
temperature of 37 degree Celsius using a circulating water bath. This water 
bath circulates water of 37 degree Celsius through the outer compartment of 
the reservoirs and the bubble trap and thus maintains the temperature of the 
perfusion solution throughout the experiment. 
 
RECORDING HEART RATE: 
                     The heart was mounted in the Langendorff setup and perfused 
with Normal Extracellular solution and allowed to beat on its own pace. 
                      Surface electrocardiogram was recorded using three electrodes 
touching the surface of the heart connected to CMCdaq ECG amplifier 
(designed by the Department of Bioengineering, Christian Medical College, 
Vellore).  The negative electrode was placed on the right atrium and the 
positive electrode was placed on the left ventricle. The third electrode was 
used as ground electrode to cancel noise in the recording. This placement of 
 
 
electrodes was similar to Lead II ECG placement. The electrodes were 
connected to CMCdaq ECG amplifier which in turn was connected to the 
computer. The ECG tracings were recorded using CMCdaq software in the 
computer. The heart rate was calculated from the surface electrocardiogram 
tracings obtained.  
          
                 ECG preamplifier                                CMCdaq 
Figure 12: Recording the Surface ECG from the isolated rat heart using 
ECG preamplifier and CMCdaq 
 
 
EXPERIMENT PROTOCOL: 
Ethical clearance for the use of rats and for the protocol used in this study was 
obtained from the Institutional Animal Ethics Committee. (IAEC N0: 
16/2013). The procedures were performed under anaesthesia and all efforts 
were made to minimize suffering. 
                  Wistar rats weighing between 200grams to 300 grams were used in 
this study. Both male and female rats were used. These rats were housed and 
maintained in the animal house till the experiments were conducted. A total of 
18 rats were used for the study and 6 rats were used for standardization. 
                              
                                 Figure 13:  Wistar Rat 
ANAESTHESIA: 
             For anaesthesia, intraperitoneal injection of Ketamine was given to the 
rat at a dose of 100milligram per kilogram of body weight. The animals were 
then fixed to a plastic board with micro-pore tapes attached on all four limbs. 
Complete anaesthesia was confirmed by pinching the sole and then the 
procedure was started. 
 
 
PROCEDURE: 
                The region of chest was wiped with distilled water prior to incision.  
A sub-costal incision was given just below the xiphi sternum and the skin and 
the muscle layer beneath were cut to open the abdominal cavity. Then the 
diaphragm was cut open to expose the chest cavity. The ribs were cut on both 
sides and the heart was completely exposed.  
                         
               Figure 14: Sub-coastal incision below the xiphi sternum 
                       
Figure 15: Exposure of heart 
Heart 
 
 
The aorta was identified and a bulldog artery clamp was applied around the 
aorta. Then the heart and the bulldog clamp were lifted together and the heart 
was excised carefully along with a sufficiently long piece of aorta using a fine 
scissors.  
                  Immediately after removing the heart from the chest cavity, it was 
placed in a petri dish containing the ice cold Normal Extracellular solution. 
The blood inside the heart was removed by slow massaging. If this blood is not 
removed, it might get clotted inside the vessels and chamber of heart and 
interfere in perfusion and contraction of heart. Immediately the aorta was 
cannulated and the heart was mounted in the Langendorff setup and the 
coronaries were perfused with Normal Extracellular solution maintained at 37 
degree Celsius and at the rate of 10ml per minute. 
 
              
Figure 16: Heart isolated from the rat kept in a petri dish containing cold 
normal extracellular solution 
 
 
 The perfusing solutions were stored in the reservoirs and then they pass 
through the bubble trap before entering the aorta. This bubble trap prevents 
entry of air bubble into the aorta from the perfusion system. The heart is 
allowed to beat on its own without any external pacing.  Surface 
electrocardiogram was recorded using surface electrodes, and CMCdaq 
amplifier connected to a computer. The analog data was acquired through 
computerized CMC data acquisition system. 
 
          
Figure 17:  Recording of surface electrogram from isolated perfused rat 
heart 
 
 
 
Figure 18 : CMCdaq computerized data acquisition system 
 
 
 
DRUG DOSE STANDARDISATION: 
                      6 rats were used for standardization of drug dosage. Different 
doses  of the 2 drugs – Phenylephrine(1μM, 10μM, 20μM) and Neomycin 
(2mM, 2.5mM, 5mM) , were tried on different rats and the dose was 
standardized. The final standardized dose was 10μM for Phenylephrine and 
2mM for Neomycin. 
 
 
 
EXPERIMENTAL DESIGN: 
                The experiment protocol had 3 groups.6 rats were used in each 
group. The total number of animals used was 18. Group1 was a control group 
where the heart was isolated from the rat and immediately mounted in the 
Langendorff setup and perfused with the modified extracellular solution for 45 
minutes at 37 degree Celsius and constantly oxygenated. This was done to see 
if there was any trend of increase or decrease of heart rate with time. The heart 
rate was computed from the surface ECG recorded using the CMCdaq 
amplifier and software. 
               Group2 was an intervention group with Phenylephrine. The hearts 
were isolated from the rat and mounted and perfused in Langendorff mode 
with modified extracellular solution at 37 degree Celsius with constant 
oxygenation for 15 minutes or more till the heart rate stabilized.  Then 
Phenylephrine 10μM was added to the perfusate and perfused for 15minutes. 
After 15 minutes the heart was again perfused with the modified extracellular 
solution for another 15 minutes to wash out the phenylephrine. Surface ECG 
was recorded throughout the experiment and heart rate was calculated from the 
ECG. 
                Group3 was another intervention group with Neomycin and 
Phenylephrine. In this set of experiments the rat hearts were isolated and 
perfused in Langendorff mode with the modified extracellular solution (37 
 
 
degree Celsius and oxygenated) till the heart rate stabilized. Then Neomycin 
2mM was added to the perfusate and after 2 minutes Phenylephrine 10μM was 
also added to the perfusate and perfused for 15 minutes. This was followed by 
wash with the modified extracellular solution for 15 minutes. The heart rate 
was calculated from the recorded surface ECG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FLOWCHART DESCRIBING THE EXPERIMENTAL DESIGN 
 
 
Compared the percentage change of the three 
groups and analysed using Kruskal-Wallis Test . 
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ANALYSIS: 
               The surface ECG was recorded continuously throughout the 
experiment using the surface electrodes connected to the CMCdaq ECG 
amplifier and the CMCdaq software.  The heart rate was calculated from the 
recorded surface ECG. The heart rate for every minute was calculated 
manually by counting the peaks (R wave) from the ECG and tabulated. The 
change in heart rate during intervention was also calculated and expressed as 
percentage change. 
 
STATISTICAL ANALYSIS: 
                The heart rate before and after the drug intervention within a group 
was compared. Since they were non-parametric paired data, they were 
analysed statistically using Wilcoxon Signed Rank test. 
The change in heart rates between the groups was also compared. These were 
non-parametric unpaired data of three independent groups (control group, 
intervention 1 group and intervention 2 group). They were analysed using 
Kruskal Wallis Test. 
Data were analysed using SPSS software (version17.0). 
A p value of less than 0.05 was considered as significant. 
IGOR Pro software (version 5.4) was also used to analyse and plot graphs. 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS: 
Representative sample of the raw tracing of the surface ECG recorded 
 
 
Figure 19: Representative ECG tracing obtained with normal 
extracellular solution perfusion 
 
 
Figure 20: Representative ECG tracing obtained by adding 
Phenylephrine 10µM in normal extracellular solution perfusion 
 
 
Heart rate was calculated manually from the recorded surface ECG and 
tabulated as follows: 
CONTROL GROUP: 
 
Time 
(min) 
Heart rate (beats/min) 
Experiment 
1 
Experiment 
2 
Experiment 
3 
Experiment 
4 
Experiment 
5 
Experiment 
6 
-5 190 160 170 90 170 110 
-4 190 150 170 90 170 120 
-3 190 160 170 100 170 100 
-2 190 160 170 100 170 100 
-1 190 160 170 100 170 100 
0 190 150 170 100 170 110 
1 190 150 170 110 170 110 
2 190 150 170 110 160 110 
3 180 150 170 110 160 110 
4 180 140 170 110 160 110 
5 190 150 160 120 160 110 
6 180 150 170 120 160 110 
7 190 150 170 110 170 110 
8 180 150 170 100 170 110 
9 180 150 170 100 160 100 
10 180 150 170 100 160 100 
11 190 150 170 110 160 100 
12 190 140 160 120 160 100 
13 180 150 160 120 160 100 
14 180 140 160 120 160 100 
15 180 150 160 120 160 110 
16 170 140 160 130 160 110 
17 180 150 160 130 160 100 
18 180 150 160 130 160 100 
19 180 150 160 130 150 110 
20 180 150 160 130 160 110 
21 170 150 150 130 160 110 
22 170 150 160 130 160 110 
23 170 150 160 130 160 100 
24 170 150 160 130 150 110 
25 170 150 160 130 160 110 
 
 
 
INTERVENTION GROUP 1: 
 (Phenylephrine 10µM) 
 
 
Time 
(min) 
Heart rate (beats/min) 
Experiment 
1 
Experiment 
2 
Experiment 
3 
Experiment 
4 
Experiment 
5 
Experiment 
6 
-5 130 160 160 110 130 150 
-4 130 160 150 110 130 140 
-3 130 160 150 110 130 140 
-2 140 160 150 110 120 140 
-1 140 160 150 110 120 150 
0 134 160 152 110 126 144 
1 160 180 160 110 150 170 
2 170 180 170 120 160 180 
3 190 180 170 140 160 190 
4 200 180 170 160 160 180 
5 190 190 180 180 160 180 
6 200 180 170 190 160 180 
7 200 210 170 200 160 190 
8 210 210 180 200 170 180 
9 210 220 170 200 180 180 
10 210 220 180 220 160 180 
11 220 230 170 220 160 170 
12 220 230 180 210 160 160 
13 220 230 190 210 160 160 
14 220 240 190 210 160 170 
15 220 230 190 210 160 180 
16 210 260 200 210 150 180 
17 210 260 210 210 160 180 
18 210 250 200 220 150 180 
19 200 230 200 210 160 180 
20 200 240 200 210 140 180 
21 200 230 190 210 120 180 
22 200 230 200 200 120 170 
23 190 210 190 200 120 170 
24 180 220 190 200 120 160 
25 180 200 190 200 110 140 
 
 
 
INTERVENTION GROUP 2:  
(Neomycin 2mM + Phenylephrine 10µM) 
 
 
Time 
(min) 
Heart rate (beats/min) 
Experiment 
1 
Experiment 
2 
Experiment 
3 
Experiment 
4 
Experiment 
5 
Experiment 
6 
-5 90 140 130 140 150 110 
-4 80 140 130 130 130 110 
-3 90 130 120 130 150 110 
-2 90 130 120 130 150 110 
-1 100 110 100 130 150 90 
0 90 130 120 132 146 106 
1 110 100 90 130 100 90 
2 100 100 100 130 60 90 
3 80 90 90 110 70 90 
4 80 80 90 100 60 90 
5 80 90 90 80 60 90 
6 80 90 80 80 60 90 
7 80 90 80 80 60 90 
8 80 80 80 80 60 90 
9 80 80 80 80 60 100 
10 80 80 80 80 60 90 
11 80 80 60 80 60 100 
12 80 80 60 70 60 100 
13 80 80 70 70 60 90 
14 80 90 70 70 60 70 
15 90 100 130 70 60 70 
16 100 90 140 70 60 90 
17 110 80 160 70 60 100 
18 110 90 180 70 60 110 
19 110 90 190 70 70 110 
20 110 90 190 70 70 130 
21 110 160 180 70 70 140 
22 110 120 180 80 80 130 
23 110 130 160 90 100 90 
24 110 160 170 90 100 70 
25 100 150 170 100 110 70 
 
 
 
. 
CONTROL GROUP: 
The calculated and tabulated heart rates were plotted against time using IGOR 
pro software for each experiment in the control group.  
 
EXPERIMENT 1: 
 
 
 
EXPERIMENT 2: 
 
 
 
 
 
 
EXPERIMENT 3: 
 
 
 
EXPERIMENT 4: 
 
 
 
 
 
 
 
 
EXPERIMENT 5: 
 
 
 
 
EXPERIMENT 6: 
 
 
 
 
 
 
 
 
 
CONTROL GROUP: 
 
                Since the basal heart rates of each rat were different, all the values 
were normalized to the basal heart rate and the mean and standard deviation 
for each minute was calculated. A graph was plotted with this mean and 
standard deviation using IgorPro software to see the effect of time on heart 
rate. 
 
 
Figure  21: A plot of heart rate of control rats versus time in isolated rat 
hearts in Langendorff mode perfused with normal extracellular solution 
at 37 degree Celsius and constantly oxygenated. There is no change in 
heart rate over 30 minutes. 
 
 
 
 
 
Figure 22: A category plot showing the change in heart rate with time in 
all six experiments 
 
 
Statistical Analysis: 
 
The basal heart rates of all six control experiments at the initial 5 minutes were 
compared to the heart rates after 10 to 15minutes by Wilcoxon Signed Rank 
Test using SPSS software. The P value was 0.345. This shows that there was 
no significant difference between these two groups. Thus the heart rate did not 
change with time. 
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INTERVENTION GROUP (Phenylephrine 10µM) 
The heart rates were calculated from the surface ECG and tabulated. These 
heart rates were plotted against time using IGORPro software for all the six 
experiments in the intervention group 1. 
EXPERIMENT 1: 
 
 
 
EXPERIMENT 2: 
 
 
 
 
 
EXPERIMENT 3: 
 
 
 
 
EXPERIMENT 4: 
 
 
 
 
 
 
 
 
 
EXPERIMENT 5: 
 
 
 
 
 
EXPERIMENT 6: 
 
 
 
 
 
 
 
EFFECT OF PHENYLEPHRINE: 
All the six rats had different basal heart rates and it was difficult to compare 
them. So the heart rates were normalized to the basal heart rate and a mean 
and standard deviation was calculated. This was plotted against time using 
IGORPro software. 
 
 
 
Figure 23: Phenylephrine 10µM produced a 44% increase in heart rate in 
isolated rat heart perfused in Langendorff mode. (n=6) 
 
 
 
 
 
 
 
Figure 24: A category plot showing the effect of Phenylephrine on heart 
rate on six experiments 
 
 
Statistical Analysis: 
                 The basal heart rates at initial 5 minutes were compared with the 
heart rates at 10 to 15 minutes to see the effect of Phenylephrine. Wilcoxon 
Signed Rank Test was used for this and SPSS software was used for analysing. 
The P value was 0.028. This shows that the increase in heart rate with 
Phenylephrine was significant. 
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INTERVENTION GROUP 2 (Neomycin 2mM + Phenylephrine 10µM) 
               The heart rates calculated and tabulated from the surface ECG were 
plotted against time for all the six experiments in the intervention group 2. 
IGORPro software was used to make these graphs. 
EXPERIMENT 1: 
 
 
 
EXPERIMENT 2: 
 
 
 
 
EXPERIMENT 3: 
 
 
 
 
EXPERIMENT 4: 
 
 
 
 
 
 
 
 
 
EXPERIMENT 5: 
 
 
 
 
EXPERIMENT 6: 
 
 
 
 
 
 
EFFECT OF NEOMYCIN + PHENYLEPHRINE: 
 
               Since the basal heart rates were different in all the rats, the heart rates 
were normalized to the basal heart rate and then they were compared. The 
mean and standard deviation was calculated and plotted against time using the 
IGORPro software. 
 
 
 
Figure 25 : Neomycin 2mM blocked the phenylephrine induced increase 
in heart rate in isolated rat heart perfused in Langendorff mode 
 
 
 
 
 
 
Figure 26: A category plot showing the effect of Neomycin+Phenylephrine 
on heart rate in six experiments 
 
Statistical Analysis: 
    The basal heart rates and the heart rates after intervention i.e., at 10 to 15 
minutes were compared to see the effect of Neomycin and Phenylephrine. This 
was analysed by Wilcoxon Signed Rank Test using SPSS software. The P 
value obtained was 0.028. This shows that there was no increase in heart rate 
with Phenylephrine in the presence of Neomycin. Also the decrease in heart 
rate by Neomycin was significant. 
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COMPARING THE THREE GROUPS: 
 
The mean and standard deviations of the heart rates (normalized) of all the six 
experiments  of three groups were plotted in the same graph for comparison. 
 
 
Figure 27:  The mean and standard deviation of all the three groups 
(Control group- red colour, Phenylephrine group- black colour, 
Neomycin+Phenylephrine group- blue colour) are shown in a single graph 
 
 
 
 
 
 
 
 
Figure 28: A category plot showing the mean heart rate with standard 
deviation before and after intervention in all three groups 
 
  
                  The heart rates at 10 to 15 minutes of all the three groups were 
compared using Kruskal Wallis Test using SPSS software. The P value was 
0.001. This shows that the inter-group variations in heart rates are significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION: 
                      
                 One of the electrophysiological properties of heart is Chronotropy. 
It is the ability of the heart to produce electrical impulses on its own. This 
property is also called as automaticity or excitability. Many studies and 
research have been done to unravel the molecular mechanism behind this 
pacemaker property of heart.  
                The Sinoatrial nodal is the pacemaker of the heart. It is a group of 
spontaneously depolarizing cells located in the right atrium near the opening 
of superior vena cava. The action potential of the Sinoatrial nodal cells is 
different from those of the working cardiomyocytes.  
Sinoatrial node action potential: 
                     
Figure 29: Sinoatrial node action potential and the ion channels involved 
 
 
                  The Sinoatrial node action potential has three phases: Phase 4 of 
Diastolic depolarisation, Phase 0 of depolarisation and Phase 3 of 
repolarisation.    
                   The cells in Sinoatrial node do not have a true resting membrane 
potential like the other cells in heart, instead they undergo a slow 
depolarisation called the Diastolic depolarisation in phase 4.   At the end of 
repolarisation the membrane potential reaches a value of -60 mV. The 
spontaneous diastolic depolarisation begins with the opening of HCN 
(Hyperpolarisation activated cyclic nucleotide gated) channels which carry a 
hyperpolarisation activated current called funny currents (If). This is an inward 
current creating depolarisation of the membrane. As the membrane depolarises 
and reaches a voltage around -50 mV, the T-type calcium channels get 
activated and produce more depolarisation. The calcium ions that entered the 
cell through open T-type calcium channels activate calcium-induced calcium 
release from the sarcoplasmic reticular stores through Ryanodine receptors 
and IP3 receptors. This increase in intracellular calcium drives the sodium 
calcium exchanger in forward mode, resulting in an inward current which 
depolarises the membrane further. When the membrane potential reaches -40 
mV, it activates the L-type calcium channels. Opening of L-type calcium 
channels causes calcium to enter into the cell and it depolarises the cell till the 
threshold potential is reached (Grant, 2009). 
 
 
                   Phase 0 of Sinoatrial action potential is due to the activated L-type 
calcium channels and increased conductance of calcium through these 
channels. Since the conductance of calcium is not as fast as sodium 
conductance, the rate of depolarisation is slow compared to that of working 
myocardial cells. Hence the action potential is called „Slow response‟ action 
potential (de Carvalho et al., 1969). 
                    Phase 3 is the repolarisation phase in Sinoatrial node action 
potential. It is due to the potassium conductance through the voltage gated 
potassium channels producing an outward hyperpolarising current. At this 
time the calcium channels become inactivated and closed. Once the cell is 
completely repolarised and reaches -60 mV, the cycle is repeated 
spontaneously.       
                 Diastolic depolarisation phase is the essence of pacemaker cell 
automaticity. Because of this slow depolarisation that occurs in the phase 4 of 
action potential, the pacemaker cells are able to produce spontaneous and 
rhythmic electrical impulses. Regarding the molecular mechanism behind the 
diastolic depolarisation, two important theories are being debated namely the 
membrane clock theory and the calcium clock theory.  
                 The membrane clock theory states that the funny currents produced 
by the HCN channels are responsible for diastolic depolarisation. These 
currents get activated on hyperpolarisation and they produce an inward 
 
 
current. And these funny current producing HCN channels are expressed only 
in the Sinoatrial node and Purkinje fibres but not in the surrounding working 
myocardiocytes. Hence the funny currents are called as pacemaker currents 
(Brown et al., 1979; DiFRANCESCO and Zaza, 1992). 
                     The other theory is the calcium clock theory. It states that the 
endoplasmic reticulum inside the cells has spontaneous and rhythmic local 
calcium release during diastole. This local calcium release drives sodium 
calcium exchanger in forward mode which extrudes one calcium ion for three 
sodium ions. This results in an inward current producing depolarisation 
(Bogdanov et al., 2001; Maltsev and Lakatta, 2007) . Thus as a local calcium 
release by an intracellular clock produces depolarisation, this theory is called 
as „Calcium clock‟ theory. 
                  The sodium calcium exchanger is emerging as the pacemaker 
current in heart. This is driven by the local calcium release from the 
endoplasmic reticulum. Endoplasmic reticulum is the major internal store of 
calcium. The endoplasmic reticulum has two calcium release channels present 
on its membrane. They are Ryanodine receptor and Inositol 1,4,5-triphosphate 
receptor (IP3R). So the local calcium release responsible for driving the 
sodium calcium exchanger in forward mode and thereby diastolic 
depolarisation can be through one of these two receptors.      
 
 
               Ryanodine receptor is a large calcium release channel present in the 
sarcoplasmic reticulum. . In skeletal muscles the Ryanodine receptor is voltage 
gated. It is regulated by calcium in cardiac cells. Calcium produced a calcium 
induced calcium release through the Ryanodine receptors in cardiac myocytes 
during systole (Griffiths and MacLeod, 2003).      
                IP3 receptor is also a calcium release channel present in the 
sarcoplasmic reticulum. This receptor needs both calcium and IP3 for its 
activation(Bootman et al., 1995). When the receptor is bound to IP3, even very 
little calcium as seen in diastolic phase can activate the receptor to release 
calcium (Gilbert et al., 1991).  Hence the role of IP3 receptor on diastolic 
calcium release can be more significant.  
                The aim of this study was to assess if  IP3 has a role in diastolic 
calcium release and thereby in rhythm generation of heart. Hence we used 
pharmacological modulators of IP3 and saw the effect of them on heart rate. 
We used Phenylephrine which is an α-adrenergic agonist. Phenylephrine binds 
with its receptor which is a G protein coupled receptor. Gq gets activated and 
this activated the membrane bound enzyme Phospholipase C (PLC). PLC 
hydrolysis PIP2 into IP3 and DAG. Thus Phenylephrine increases the 
concentration of IP3 (Scholz et al., 1988).  
                  With the addition of Phenylephrine to the perfusate in the isolated 
rat heart preparation the heart rate increased to nearly 44% and this was also 
 
 
statistically significant. (p value = 0.028) . On washing of the drug by 
perfusing with normal extracellular solution decreased the heart rate but it did 
not come back to the basal heart rate. 
          We also used Neomycin which binds with the membrane phospholipids 
and blocks the action of PLC on them. Thus Neomycin blocks the production 
of IP3 and decreased its concentration (Walz et al., 2000).  On using Neomycin 
along with Phenylephrine in the perfusate of the isolated perfused rat heart, the 
increase in heart rate seen with Phenylephrine alone was not seen. Also a 
decrease in heart rate was seen with Neomycin and Phenylephrine in the 
perfusate and this was also statistically significant (p value = 0.028). On wash 
off of the drugs by perfusing with normal extracellular solution, the heart rate 
increased initially followed by a decrease. This shows that Neomycin is 
washed away faster than Phenylephrine which exerts its effect and then weans 
off.      
                  Our results show that Phenylephrine which acts by increasing IP3 
concentration increases the heart rate in an isolated heart preparation. Since 
this is an isolated heart preparation, this effect of Phenylephrine is the direct 
effect on heart. To confirm that Phenylephrine acts through IP3 pathway, we 
have used Neomycin which blocks the production of IP3. In the presence of 
Neomycin the increase in heart rate by Phenylephrine was not seen. This 
confirms that Phenylephrine acts by increasing IP3 concentration.  The result 
 
 
allows us to conclude that calcium release through IP3 receptors may be an 
important rhythm-generating mechanism. 
                   The results in our control group show that the heart rate of the 
isolated perfused rat hearts did not change with time. Since the hearts were 
perfused and ECG was recorded for 45 minutes any change in heart rate with 
time can act as a confounder in this study. Hence a control group was done 
without any intervention for the same 45 minutes and it was found that the 
heart rate did not change with time. 
                       The results from this study show that when the concentration of 
IP3 is increased with Phenylephrine the heart rate increases and the heart rate 
does not increase when Neomycin is added along with phenylephrine which 
blocks the production of IP3. Thus IP3 definitely has a role in rhythm 
generation of heart.     
                      This role of IP3 on rhythm generation or Chronotropy has not 
been shown in adult cardiomyocytes in any studies before. The positive 
chronotropic effect of IP3 has been shown in neo-natal rat cardiomyocytes and 
in embryonic stem cell derived cardiomyocytes (Hadad et al., 2013; Kapur and 
Banach, 2007; Méry et al., 2005). In these two conditions the IP3 receptor 
expression is more than Ryanodine receptor expression in these 
cardiomyocytes and the major calcium handling is done by IP3 receptors 
(Rosemblit et al., 1999). As the cardiomyocytes differentiate , there is 
 
 
increased expression of Ryanodine receptors and the calcium handling 
mechanism is taken over by other calcium channels (Fu et al., 2006). But the 
IP3 receptor expression is not completely lost. It is also expressed in adult 
cardiomyocytes but in less number compared to Ryanodine receptors. And it 
has a definitive role in diastolic calcium release which is shown in this 
experiment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY: 
 
                   Diastolic depolarisation is the essence of pacemaker automaticity. 
Two important theories have been proposed regarding the molecular 
mechanism behind the diastolic depolarisation. They are the „Membrane clock 
theory‟ and the „Calcium clock theory‟ 
                  According to the calcium clock theory, the endoplasmic reticulum 
which is the main internal store of calcium has spontaneous and rhythmic local 
calcium release events. This local calcium release drives the sodium calcium 
exchanger in forward mode which extrudes one calcium ion for three sodium 
ions resulting in an inward current. This inward current produces 
depolarisation of the membrane during diastolic phase. Since a local calcium 
release by an intracellular clock produces depolarisation, this is called as 
„calcium clock‟. Thus the sodium calcium exchanger is emerging as the 
pacemaker current.  
                  The local calcium release that drives the sodium calcium exchanger 
in forward mode is from the endoplasmic reticulum. The endoplasmic 
reticulum has two calcium release channels: the Ryanodine receptor and the 
IP3 receptor. This study was aimed to assess if IP3 has a role in this diastolic 
calcium release and thereby in rhythm generation. 
                     
 
 
 
                   The results of this study show that Phenylephrine increases the 
heart rate in an isolated rat heart preparation perfused with normal 
extracellular solution at 37 degree Celsius and oxygenated constantly. 
Phenylephrine is known to act by increasing IP3 concentration. To confirm 
that the increase in heart rate by Phenylephrine was because of increased IP3 
concentration, we used Neomycin which blocks the production of IP3. In the 
presence of Neomycin the increase in heart rate by Phenylephrine was not 
seen. This confirms that Phenylephrine acts by increasing IP3 concentration. 
Thus the results show that calcium release through IP3 is an important 
mechanism in rhythm generation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION: 
 
                        In an isolated rat heart preparation perfused with normal 
extracellular solution in Langendorff mode, addition of Phenylephrine 
increased the heart rate. In the presence of Neomycin, the increase in heart rate 
by Phenylephrine was not seen. These results show that Phenylephrine can 
increase heart rate and it acts by increasing the concentration of IP3. Thus 
calcium release through IP3 receptor in diastolic phase has a role in rhythm 
generation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIMITATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
LIMITATIONS: 
Limitations of our study: 
     
                 The pharmacological manipulator used in our study:  Neomycin 
does not have specific actions only on IP3. They can also act on other channels 
and give a non-specific effect. Neomycin has been found to block L-type 
calcium channels and Ryanodine receptors also.  Even though many studies 
have used Neomycin as an IP3 antagonist, this is a limitation in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FUTURE COURSE 
OF THE STUDY 
 
 
 
 
 
 
 
 
 
 
FUTURE COURSE OF THIS STUDY: 
 
- See the effect of IP3 manipulation on heart rate by using more specific 
pharmacological modulators or using  knockout animals. 
- To do experiments to see if Ryanodine receptor has any role in diastolic 
calcium release. 
- Compare the role of IP3 receptor to Ryanodine receptor in diastolic 
calcium release and thereby rhythm generation. 
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